indiamed
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
facebook x icon x icon linkedin linkedin
all-news

MoU between Kalam Institute of Health Technology and CSIR – CGCRI, Kolkata

IMT News Desk
The Kalam Institute of Health Technology (KIHT), at the AP MedTech Zone, Visakhapatnam and Council of Scientific & Industrial Research (CSIR) - Central Glass & Ceramic Research Institute (CGCRI), Kolkata have signed MoU on 04 January 2019. KIHT created with support of DBT (Dept. of Biotechnology) whose mandate is to reduce country’s import dependency and increase affordable medical devices through indigenous manufacturing, while CSIR-CGCRI mission is to provide scientific industrial research and development in the area of glass, ceramics and related materials that maximizes the economic, environmental and societal benefit for the people of India. Both these institutes are going to work together to transform the medical device implant industry where glass and ceramics are highly applied in bio-implants. For the fiscal year 2017– 2018, the import value of Biomedical Implants is approximately INR ₹2100Crores while export value is INR ₹400Crores. As a national lab CSIR-CGCRI is dedicated to carry out applied research in the fields of Bio Active Coating for Orthopaedic and Dental Application and Ceramic based hip joint prostheses and hydroxyapatite based integrated orbital implants which can significantly reduce the import dependency in the Biomedical implant and Biomaterial sector. KIHT can facilitate these innovations of CSIR-CGCRI using its e-Auction portal where any interested Indian manufacturer can bid the technology and start indigenously manufacturing thereby reducing import dependency. In addition, KIHT would support CSIR-CGCRI scientists, researchers, and students to engage with medical device companies, innovators, incubatees, R&D institutions, and technical service providers. KIHT also facilitates access to the Common Scientific Facilities (CSFs) of its affiliate company, AMTZ for accelerating medical product development and commercialization. Further, both the institutes are going to encourage and facilitate industries, innovators, biomedical and related R&D institutions for exchange of information in relation to healthcare technology.

Recommended

Regeneron Secures 23andMe in $256 Million Bankruptcy Auction

Vaidya Smita Naram bags Lifetime Achievement Award at 67th International Global Ayurveda Conference

Venus Remedies joins United Nations Global Compact

SBI Securities collaborates with Sightsavers India

DavaIndia launches first multilingual pharmacy app in Varanasi

Hospital Superbug Turns Medical Plastics into a Food Source, Study Reveals

Wadi Surgicals unveils accelerator-free nitrile gloves under its flagship brand Enliva

Massive Turnover, Growing FDI: India’s Pharma Sector at a Crossroads

Indiamedtoday

A premier media platform empowering healthcare professionals with critical business insights, news, and innovations to excel in a rapidly evolving industry.

EMAIL editorial@indiamedtoday.com

EMAIL sales@indiamedtoday.com

quick links

news health it interview opinion strategy magazine privacy policy terms and conditions

subscribe to our newsletter

Stay updated with the latest breakthroughs in Indian healthcare, medical research, and wellness insights.

    follow us

    facebook x icon x icon linkedin linkedin
    Copyright © 2025 INDIAMED TODAY Marketed By Screetract Solutions